DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at the 2018 ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
March 20, 2018 — Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad ...
March 20, 2018 — Among people younger than 75 years who were given clot busters to treat a heart attack, taking the more ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC) magazine ...
March 20, 2018 — Among people with a type of hole in the heart, known as patent foramen ovale (PFO), those who received ...
March 19, 2018 — The combined rate of death from any cause, heart attack or stroke within 18 months was not ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
A discussion with Hitinder Gurm, M.D., MBBS, FACC, professor, internal medicine, and associate chief clinical officer ...
Insights from the STS/ACC TVT Transcatheter Valve Registry, presented at the American College of Cardiology (ACC) 2018 ...
An economic analysis of the DEFINE-FLAIR study comparing FFR vs. iFR, found a cost savings of nearly $900. The late ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
March 14, 2018 — A late-breaking analysis of the landmark COMPASS study presented at the American College of Cardiology ...
The Zoll LifeVest is a temporary, wearable defibrillator designed as a safety net for patients, especially those being ...
March 13, 2018 – HeartFlow, Inc. today announced that it has entered into a licensing and technology transfer agreement ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
March 12, 2018 — Medtronic plc unveiled outcomes from the CoreValve U.S. Pivotal Extreme Risk Study and the real-world ...
March 12, 2018 — Philips announced health economic results from the DEFINE FLAIR clinical trial comparing cost ...
Sammy Elmariah, M.D., MPH, interventional structural heart disease, Massachusetts General Hospital, discusses the ...
March 21, 2018